anti-human MAGE-C2 (CT10) Clone LX-CT10.5




InVivoMAb anti-mouse NKG2D (CD314) (Clone: CX5)

The LX-CT10.5 monoclonal antibody reacts with human melanoma-associated antigen C2 (MAGEC2), also known as CT10 and HCA587. MAGEC2 is one of many cancer/testis (CT)-antigens. CT antigens are thought to repress the expression of some genes necessary for cellular differentiation. Normally, MAGEC2 expression is restricted to male germ cells in the testis. However, MAGEC2 is abnormally expressed in a wide variety of malignancies, including hepatocellular carcinoma, melanoma, bladder cancer, breast cancer, sarcoma, and lung cancer. MAGEC2 positive tumors are associated with reduced overall survival rates in prostate, hepatocellular, breast, and non-small cell lung carcinomas. Since MAGEC2 is highly expressed in cancer cells but absent from normal adult tissues, it is considered an ideal target for cancer immunotherapy. The LX-CT10.5 antibody is useful for identifying MAGEC2 expressing cells in immunohistochemical studies.



This Antibody Is Useful For:

Immunohistochemistry (paraffin)
Western blot


ALWAYS specifically formulated for in vivo use and feature:

95% purity

Ultra-low endotoxin levels

Preservative, stabilizer, and carrier protein-free


Recommended Control and Buffer:


mouse IgG2a isotype control, unknown specificity

InVivoMAb mouse IgG2a isotype control, unknown specificity


The C1.18.4 monoclonal antibody is ideal for use as a non-reactive isotype-matched control for mouse IgG2a antibodies in most in vivo and in vitro applications.




InVivoPure pH 7.0 Dilution Buffer


InVivoPure™ dilution buffers are specifically formulated and tested to satisfy the stringent requirements for in vivo applications. They are extremely low in endotoxin, have been screened for murine pathogens, tested in animal models for toxicity and are formulated with respect to buffer composition and pH to satisfy the requirements of Bio X Cell’s antibodies.